SELL Alert: This FDA Approval is Not What It Seems
The FDA’s decision on this company’s abuse-resistant drug makes it a sell…
Subscribe to AGORA Financial’s FDA Trader Today!
Agora Financial’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.
Subscribe Today! Already A Member? Log In